fibromyalgia

Overview
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, along with fatigue, sleep disturbances, and cognitive issues often described as “fibro fog.” It affects how the brain and spinal cord process pain signals, amplifying painful sensations. Despite being a non-degenerative and non-inflammatory condition, fibromyalgia significantly impacts quality of life and daily functioning. The cause isn’t fully understood, but it likely involves a mix of genetic, neurological, and environmental factors.

Why It’s Important
Fibromyalgia is often misunderstood and underdiagnosed, leading many people to suffer without proper treatment or support. It doesn’t cause physical damage to tissues or organs, but the chronic pain and fatigue can severely affect mental health, work productivity, and social relationships. Early diagnosis and a multidisciplinary treatment approachcan help individuals better manage symptoms and improve quality of life.

Quick Facts

  • Affects mostly women (about 80–90% of cases)

  • Onset typically between ages 30–50, but can occur at any age

  • Estimated to affect about 4 million adults in the U.S. (CDC)

  • Chronic condition, but symptoms can fluctuate in severity

  • Not an autoimmune disease, but often coexists with conditions like lupus or rheumatoid arthritis

What Happens in the Body
Fibromyalgia involves abnormal pain processing in the central nervous system. The brain becomes hypersensitive to pain signals, possibly due to imbalances in neurotransmitters like serotonin, dopamine, and norepinephrine. This leads to an exaggerated pain response to stimuli that wouldn't normally be painful. Stress, trauma, infections, or genetic predisposition may trigger or worsen the condition.

Common Signs and Symptoms

  • Widespread body pain lasting at least 3 months

  • Fatigue, even after adequate sleep

  • Sleep disturbances, including non-restorative sleep

  • Cognitive issues ("fibro fog") — memory lapses, trouble concentrating

  • Headaches or migraines

  • Irritable bowel syndrome (IBS)

  • Depression or anxiety

  • Sensitivity to temperature, noise, or light

Diagnosis

  • No definitive lab test — diagnosis is clinical

  • Based on criteria from the American College of Rheumatology: widespread pain index and symptom severity scale

  • Rule out other conditions like rheumatoid arthritis, lupus, or hypothyroidism

  • May involve blood tests, physical exams, and a detailed history
    See a doctor if:

  • You have persistent, unexplained pain, fatigue, or sleep issues that interfere with daily life

  • Your symptoms have lasted for more than 3 months

Treatment and Management
There is no cure, but many people can manage symptoms with a combination of approaches:

  • Medications:

    • FDA-approved: pregabalin (Lyrica), duloxetine (Cymbalta), milnacipran (Savella)

    • Others: pain relievers, antidepressants, sleep aids

  • Physical therapy and gentle exercise (e.g., walking, swimming, yoga)

  • Cognitive-behavioral therapy (CBT) and stress management

  • Sleep hygiene strategies

  • Dietary adjustments and nutritional support

  • Support groups and patient education

Risks and Complications

  • Reduced quality of life due to chronic pain and fatigue

  • Depression and anxiety

  • Work disability or social isolation

  • Risk of overuse of pain medications if not managed properly

Who Is at Risk

  • Women, especially during middle age

  • Individuals with a family history of fibromyalgia

  • People with chronic stress, trauma, or PTSD

  • Those with rheumatic diseases, such as lupus or RA

  • People with sleep disorders

Related Conditions

  • Irritable bowel syndrome (IBS)

  • Chronic fatigue syndrome

  • Migraine or tension headaches

  • Temporomandibular joint disorders (TMJ)

  • Depression and anxiety disorders

When to See a Doctor

  • When you experience widespread pain, fatigue, and concentration issues for more than a few weeks

  • If your symptoms interfere with your ability to work or function daily

  • If you have coexisting mood disorders or suspect another underlying condition

Last Updated: June 28, 2025